Personalized Stroke Prevention and Anticoagulation Strategies After Atrial Fibrillation Ablation

In the field of cardiac electrophysiology, atrial fibrillation (AF) poses a significant risk for ischemic stroke, heart failure, and increased mortality. Catheter ablation is now a cornerstone procedure for rhythm control, with documented superiority over antiarrhythmic drugs in maintaining sinus rhythm and enhancing patient outcomes. Yet, despite procedural success, a persistent risk of thromboembolic events remains due to factors such as silent AF recurrences, underlying atrial dysfunction, and persistent prothrombotic states. Traditional risk models, including the CHA₂DS₂-VASc score, are widely used for guiding anticoagulation, but were primarily developed for pre-ablation populations and may not fully account for the nuanced, dynamic risk profile following ablation. Recent studies highlight the limitations of applying a uniform anticoagulation strategy, showing that both stroke and bleeding risks are often misestimated in the post-ablation setting, thus fueling debate about optimal management.Despite growing recognition of these issues, the medical community has yet to reach consensus on the best methods for individualizing antithrombotic therapy after AF ablation. Ongoing research has identified potential roles for advanced cardiac imaging, novel blood-based biomarkers, and continuous rhythm monitoring in refining stroke risk stratification, but integration into clinical practice is inconsistent. This underscores the need for prospective validations, multi-parametric risk models, and systematic evaluation of emerging biomarkers and procedural factors. Consequently, there is a clear gap in evidence-based guidelines addressing how to safely tailor anticoagulation decisions to patient-specific risk following AF ablation.This Research Topic aims to advance understanding and implementation of personalized strategies for stroke prevention and anticoagulation in patients post-AF ablation. It seeks to address how dynamic and individualized assessments can improve the balance between minimizing stroke risk and avoiding unnecessary bleeding, integrating new clinical, imaging, and biomarker data into risk prediction. Ultimately, the goal is to inform more precise, patient-centered protocols that improve outcomes and quality of life in this growing patient population.To gather further insights in post-ablation care for AF patients, contributions are sought that explore both opportunities and limitations within this context. We welcome articles addressing, but not limited to, the following themes:- Personalization and re-evaluation of traditional stroke risk factors after AF ablation - The roles of silent AF recurrence, atrial remodeling, and advanced imaging in risk prediction - Identification and validation of circulating biomarkers relevant to thromboembolic risk - Innovative algorithms and dynamic risk assessment tools for tailoring anticoagulation - Clinical and economic outcomes of individualized vs. standard anticoagulation strategies - Decision frameworks for safe reduction or cessation of anticoagulation after ablation - Patient perspectives and quality of life in relation to personalized stroke prevention strategies Articles may focus on patients undergoing catheter ablation for atrial fibrillation, but should not include surgical ablation or those with additional indications for permanent anticoagulation unrelated to AF. Topic editors: Dong-Hyeok Kim, Sotirios Nedios, Lan Shen Source: https://www.frontiersin.org/research-topics/82633/personalized-stroke-prevention-and-anticoagulation-strategies-after-atrial-fibrillation-ablation